Registry for HF20 for Pediatric CRRT Under Emergency Use Authorization
Evaluation of the HF20™ Filter for Pediatric Continuous Renal Replacement Therapy (CRRT)
Sponsor: Baxter Healthcare Corporation
Listed as NCT04836026, this observational or N/A phase trial focuses on Acute Kidney Injury and Pediatric Kidney Disease and remains completed. Sponsored by Baxter Healthcare Corporation, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2024 — Jul 2024 [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Feb 2023 — Jan 2024 [monthly]
Enrolling By Invitation
-
Sep 2022 — Feb 2023 [monthly]
Enrolling By Invitation
▶ Show 1 earlier version
-
May 2021 — Sep 2022 [monthly]
Enrolling By Invitation
First recorded
Jan 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- Children's Hospital Medical Center, Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .